Novartis AG Current Liabilities
Novartis AG (NVSEF) had Current Liabilities of $27.28 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:CurrentLiabilities · last filed 2026-02-04
- 2025-12-31: Current Liabilities $27.28B.
- 2025-06-30: Current Liabilities $31.71B.
- 2024-12-31: Current Liabilities $28.69B.
- 2024-06-30: Current Liabilities $27.61B.
| Period end | Current Liabilities |
|---|---|
| 2025-12-31 | $27.28B 20-F · filed 2026-02-04 |
| 2025-06-30 | $31.71B 6-K · filed 2025-07-17 |
| 2024-12-31 | $28.69B 20-F · filed 2026-02-04 |
| 2024-06-30 | $27.61B 6-K · filed 2024-07-18 |
| 2023-12-31 | $26.39B 20-F · filed 2025-01-31 |
| 2023-06-30 | $31.91B 6-K · filed 2023-07-18 |
| 2022-12-31 | $28.66B 20-F · filed 2024-01-31 |
| 2022-06-30 | $27.65B 6-K · filed 2022-07-19 |
| 2021-12-31 | $30.21B 20-F/A · filed 2023-05-15 |
| 2021-06-30 | $29.63B 6-K · filed 2021-07-21 |
| 2020-12-31 | $33.06B 20-F · filed 2022-02-02 |
| 2020-06-30 | $29.38B 6-K · filed 2020-07-21 |
| 2019-12-31 | $28.26B 20-F · filed 2021-01-26 |
| 2019-06-30 | $30.11B 6-K · filed 2019-07-18 |
| 2018-12-31 | $29.61B 20-F · filed 2020-01-29 |
| 2018-06-30 | $27.94B 6-K · filed 2018-07-18 |
| 2018-01-01 | $23.40B 20-F · filed 2019-01-30 |
| 2017-12-31 | $23.40B 20-F · filed 2019-01-30 |
| 2016-12-31 | $22.21B 6-K · filed 2018-01-24 |